The FDA vs. a doctor’s cancer cure & his patients

The FDA, which instigated four grand juries and two trials during its 12-year campaign to put Stanislaw Burzynski in prison, said it did not matter whether the Texas physician’s unconventional cancer treatments saved people’s lives. The point was that he had failed to get the FDA’s permission first. Continue reading

The FDA vs. a doctor’s cancer cure & his patients

The FDA, which instigated four grand juries and two trials during its 12-year campaign to put Stanislaw Burzynski in prison, said it did not matter whether the Texas physician’s unconventional cancer treatments saved people’s lives. The point was that he had failed to get the FDA’s permission first. Continue reading

How the FDA Impedes Innovation

[I]nnovations get better over time. But if you impede the first generation the second generation may never come into existence and, as Mandel notes, no first-generation device could satisfy the FDA’s conditions. It’s like refusing to give the Wright Brothers a license to fly because their first airplane only flew for 59 seconds.

The FDA, Avastin, and death panels

“The FDA, stuck in its 1960s Thalidomide glory days mindset, denies Americans access to life-saving drugs. …[D]espite its intentions, [the FDA] drives up the costs of medicines & often dries up the supply chain altogether. America is currently facing a shortage of about 246 drugs – a record high.” – Milton Wolf, MD

De facto death panels: all four pieces in place

All 4 pieces are in place for gov’t to deny life-saving medicine: Health Info. Technology to track doctors, comparative effectiveness research to decide what works, Accountable Care Orgs. to control doctors’ practice, & end-of-life counseling to inform patients. Greg Scandlen explains.